ARCHIVES

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

NCI Offers Bibliography On Risk Communication.

March 23, 2001

Cediranib Demonstates Control In Alveolar Soft Part Sarcoma

May 31, 2013

DCPC BSC Committee Endorses Three Research Concepts

April 17, 1987

DCT Board Pediatric Phase 1 Studies, Effort to Assess Obstacles To Clinical Trials

July 6, 1984

NCAB Committee, SORDS Agree On New Training Grants In Surgical Oncology

January 11, 1985

In Brief: NCFA Offers Grants For Research On Impact Of DRGs; ACCC Leaders Dispute HCFA Chief

March 8, 1985